Chemomab Therapeutics Ltd DRC (CMMB)

US · Healthcare · Biotechnology

$2.80+5.66%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-2.2M

EPS

$-1.40

EPS estimate

$0.00

Market cap

$19.9M

Forward P/E

12.9

P/B

2.39

Book value

$1.20

EPS (TTM)

$-0.96

52-week high

$3.58

52-week low

$1.35

50-day MA

$1.93

200-day MA

$1.84

Beta

0.76

Analysts rate Chemomab Therapeutics Ltd DRC a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $5.00.

Insiders

12.19%

Institutions

8.36%

Fund	Stake
Advisory Services Network, LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Chemomab Therapeutics Ltd DRC — free to start.

Data updated 2026-09-18.